Congressional Budget Office Predicts Coronavirus Will Cost US Economy $15.7 Trillion

According to a recent forecast released by the Congressional Budget Office (CBO), the US is on track to lose approximately $7.9 trillion worth of economic activity over the next ten years, regardless of the federal government’s astronomical stimulus spending in order to prop up the economy.

Although many restrictions across the US are being lifted and both consumers and businesses are slowly starting to recover, the financial effects of the coronavirus pandemic are most likely going to be felt well into fiscal 2030. The report estimates that real economic output will be reduced by at least 3% when compared to previous pre-pandemic estimates, meanwhile nominal GDP will see a reduction of 5.3% – which translates to approximately $15.7 trillion.

Furthermore, the CBO is anticipating GDP levels to drop by the most in US history in the second quarter of 2020, while the month of May will have an unemployment rate of approximately 20% – the highest since the Great Depression. As a result, Senator Chuck Schumer is calling on the Senate to approve another round of fiscal stimulus in order to mitigate the impending negative impacts on the economy.

Information for this briefing was found via CNBC and the Congressional Budget Office. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is This the Most Overlooked Critical Mineral? (+1000% Move) | Guy Bourassa – Scandium Canada

Is Gold Entering a New 15-Year Cycle? | Rob Husband

A 100,000 Ounce Per Year Gold Plan in Utah | Scott Trebilcock — Revival Gold

Recommended

Silver47 Launches 7,000-Meter Hughes Drill Program In Nevada

Advanced Gold Acquires Nevada Property With Historic Production At 1,611 g/t Silver

Related News

Gilead’s Antiviral Drug Fails to Treat Coronavirus, Preliminary Study Shows

Gilead Sciences Inc (NASDAQ: GILD) has been running a randomized clinical trial on the experimental...

Thursday, April 23, 2020, 04:16:38 PM

Retail and Office Tenants Anticipate Increasing Costs, Reduced Revenue Due to Coronavirus

As a result of the coronavirus pandemic, the commercial real estate industry has been struggling...

Thursday, June 25, 2020, 02:45:00 PM

US Consumer Sentiment Slumps to Decade Low Amid Delta Variant, Inflation Concerns

Americans’ optimism surrounding the recovery of the US economy slumped to the lowest in a...

Sunday, August 15, 2021, 03:05:00 PM

April New Vehicle Sales Lowest Since 1990’s

Edmunds, which serves as an online resource for automotive information, recently published data on new...

Sunday, May 3, 2020, 10:04:00 AM

Datametrex Partners With Lab For COVID-19 Testing

Datametrex AI (TSXV: DM) announced this morning that it has entered into a strategic partnership...

Thursday, May 21, 2020, 09:37:53 AM